EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Survival Differences of Localized Papillary Renal Cell Carcinoma in African Americans vs. European Americans

Maximilian Filzmayer, Federico Polverino, Michele Petix, Leonardo Quarta, Filippo Orlandi, Jordan A Goyal, Nicola Longo, Luca Carmignani, Alberto Briganti, Salvatore Micali, Shahrokh F Shariat, Clara Humke und 5 weitere

Journal of Racial and Ethnic Health Disparities · 13.06.2026

DOI: 10.1007/s40615-026-03038-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Racial and Ethnic Health Disparities, online erschienen am 13.06.2026. Verfasst von Maximilian Filzmayer und 16 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Canada. filzmayer@med.uni-frankfurt…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Johann Wolfgang Goethe-Universität, Frankfurt am Main.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

African Americans exhibit a higher prevalence of papillary renal cell carcinoma (pRCC). We assessed overall and cause-specific survival differences between African Americans and European Americans with surgically treated localized pRCC.

Methods

African Americans and European Americans who underwent nephrectomy for T1b–2 N0 M0 pRCC were identified within the Surveillance, Epidemiology and End Results database (2004–2021). Propensity score matching (PSM) was applied, and multivariable Cox regression as well as competing-risks regression (CRR) models were fitted.

Results

Of 3,707 patients, 1,345 (36.3%) were African Americans and 2,362 (63.7%) were European Americans. After PSM, no significant differences in socioeconomic, demographic, or tumor-specific characteristics remained between the two groups. Overall survival (OS) rates at 120 months after nephrectomy were 59.4% in African Americans vs. 66.9% in European Americans ( p = 0.026). In multivariable Cox regression models, the African American group was associated with higher overall mortality (hazard ratio [HR] 1.24, 95% confidence interval [CI]: 1.05–1.47, p = 0.013). Other-cause mortality (OCM) at 120 months after nephrectomy was higher in African Americans (29.0% vs. 22.2%), while cancer-specific mortality (CSM) did not differ (11.0% vs. 10.3%) between the two populations. Finally, in multivariable CRR models, the African American group predicted higher OCM (HR 1.33, 95% CI: 1.08–1.64, p = 0.007), but did not affect CSM (HR 1.06, 95% CI: 0.77–1.45, p = 0.7).

Conclusion

In surgically treated localized pRCC, OS in African American patients is lower compared to European American patients. This difference in OS is not explained by CSM. Instead, it reflects significantly higher OCM in African American patients.

Schlagwörter

Stichwörter der Autor:innen

African AmericanNephrectomyPapillary renal cell carcinomaRaceSEERSurvival

Autor:innen und Institutionen

  • Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Canada. filzmayer@med.uni-frankfurt.de.
  • Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany. filzmayer@med.uni-frankfurt.de.
  • Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Canada.
  • Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy.
  • Università degli Studi di Milano, Milan, Italy.
  • Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.

Förderung

  • Johann Wolfgang Goethe-Universität, Frankfurt am Main

Zitieren

APA

Filzmayer, M., Polverino, F., Petix, M., Quarta, L., Orlandi, F., Goyal, J. A., Longo, N., Carmignani, L., Briganti, A., Micali, S., Shariat, S. F., Humke, C., Traumann, M. I., Wenzel, M., Saad, F., Chun, F. K. H., & Karakiewicz, P. I. (2026). Survival Differences of Localized Papillary Renal Cell Carcinoma in African Americans vs. European Americans. Journal of Racial and Ethnic Health Disparities. https://doi.org/10.1007/s40615-026-03038-3

Vancouver

Filzmayer M, Polverino F, Petix M, Quarta L, Orlandi F, Goyal JA, et al. Survival Differences of Localized Papillary Renal Cell Carcinoma in African Americans vs. European Americans. Journal of Racial and Ethnic Health Disparities. 2026. doi:10.1007/s40615-026-03038-3

BibTeX
@article{Filzmayer2026,
  author = {Filzmayer, Maximilian and Polverino, Federico and Petix, Michele and Quarta, Leonardo and Orlandi, Filippo and Goyal, Jordan A and Longo, Nicola and Carmignani, Luca and Briganti, Alberto and Micali, Salvatore and Shariat, Shahrokh F and Humke, Clara and Traumann, Miriam I and Wenzel, Mike and Saad, Fred and Chun, Felix K H and Karakiewicz, Pierre I},
  title = {Survival Differences of Localized Papillary Renal Cell Carcinoma in African Americans vs. European Americans},
  journal = {Journal of Racial and Ethnic Health Disparities},
  year = {2026},
  doi = {10.1007/s40615-026-03038-3}
}
Kostenlos starten →